Trial Details
UNKNOWNBasic Information
| Clinical ID | c1416 |
|---|---|
| Identifier | NCT05072782 |
| Trial Title | Management of Moderate POstoperative Recurrence in Crohn's Disease: a randoMizEd contROLled Trial of Therapeutic Escalation, the POMEROL Trial. (POMEROL) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease |
| Interventions | DRUG: Infliximab CT-P13|DRUG: Immunosuppressors (Thiopurines or Methotrexate) |
Participant Information
| Sponsor | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives |
|---|---|
| City | Paris |
| Country/Region | France |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2021-12-21 |
|---|---|
| Primary Completion Date | 2023-06-30 |
| Completion Date | 2024-06-15 |